Categories
Sai Life Sciences Limited — Important, 14-05-2026: Updates
14-05-2026 · 11:40 pm
Sai Life Sciences unveiled robust KPIs, projecting strong growth. Revenue is forecast to hit ₹2,192.49 Cr by Fiscal 2026, with EBITDA reaching ₹652.95 Cr (29.78% margin) and PAT at ₹348.91 Cr. The company also anticipates significant expansion in scientific staff.
No comments yet. Be the first to comment!